FEATURE ARTICLES
FDA’s real-time CRL releases face legal and operational hurdles. Could AI-assisted redaction make transparency faster and more consistent?
- Is Your Supply Chain Ready For The End Of Class VI?
- Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
- Capturing Tablet Disintegration for Improved OSD Development
- Beyond API Sourcing: Avoiding Supply Disruptions For Small Molecule Drugs
- Why We Need Pharmaceutical Engineering Project Management As A Distinct Discipline
- Your 7 Decisions To Make Before MES Configuration
- The Orange Book's Blind Spot: Process Stability And Capability
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-657049072 vaccine, pharma]( "Streamline Your mAb Manufacturing With Strategic Development And CDMO Compatibility")
Streamline Your mAb Manufacturing With Strategic Development And CDMO CompatibilityThough the journey to mAb development begins at lab scale, for clinical trials and commercial distribution, a production process must be streamlined and scalable to 2,000 L production and above.
-
Evaluation Of Novel Process Indicators For Hydrogen Peroxide Decontamination6/30/2026
Immediate, quantifiable verification replaces seven-day incubation periods. Discover how enzyme-based indicators optimize hydrogen peroxide decontamination.
-
Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes4/8/2025
The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.
-
Enabling Quality By Design9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
Spray Dried Biologics For Injectable Dosage Forms5/15/2026
Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
How Automation Is Driving Carbon Reduction10/21/2025
Manufacturers can cut emissions and boost efficiency by modernizing energy and utility systems. Explore how smart automation and analytics offer fast ROI and long-term sustainability.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 10.27.26 -- Reduce Bioprocessing Supply Risk With Manufacturing Closer To You
- 10.27.26 -- Your 7 Decisions To Make Before MES Configuration
- 10.23.26 -- Pharmaceutical Packaging Solutions For Safer, More Efficient Production
- 10.23.26 -- Qualification And Validation Of Depyrogenation Tunnels And Autoclaves
- 10.23.26 -- OPCU: Key Considerations For Building Resilient Fill/Finish Operations
NEW FOR OUR READERS
INDUSTRY NEWS
-
![white coupon banner, great topic-GettyImages-2271702407]( "Let Your Voice Help Shape Pharma Manufacturing")
Let Your Voice Help Shape Pharma ManufacturingPharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
![rating service, satisfaction-GettyImages-2221603596]( "ISPE Announces 2026 FOYA Winners")
ISPE Announces 2026 FOYA WinnersThese awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Closing the gap between manual QC and automated operation takes more than hardware. See how standards, interoperability, validation strategy, IT readiness, and organizational change shape outcomes.. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus10/23/2026
Meissner Corporation, a leading manufacturer of advanced microfiltration and therapeutic manufacturing systems for biopharmaceutical production of life-saving and life enhancing medicines, celebrated a double milestone in Athens-Clarke County: the ribbon cutting for its new X-ray irradiation services facility and the groundbreaking for Phase 2 of its Athens, Georgia, U.S.A., manufacturing campus.
-
Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 202710/22/2026
Senior pharma professionals gather in Berlin on 19-20 April for the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2027 to address the growing disconnect between investment and outcomes. The closed-door format, supported by Host Sponsor Bayer AG, fosters direct dialogue between pharmaceutical companies, contract manufacturing organisations and service providers, creating space for ongoing discussions that move beyond theory and deliver actionable solutions.
-
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services10/22/2026
LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and drug development services, today announced it has acquired Sannova Analytical, a contract research laboratory headquartered in Somerset, N.J. The acquisition expands LGM Pharma’s analytical testing services business by adding Good Laboratory Practice (GLP) bioanalysis, including peptide and oligonucleotide testing, and by bringing genotoxic and nitrosamine impurity testing, extractables and leachables evaluations, and additional elemental impurities testing to LGM Pharma’s existing cGMP analytical services. Sannova will continue to operate under its own name as Sannova Analytical, led by its current management team.
-
MVIC And Upperton Pharma Solutions Announce Strategic Collaboration10/20/2026
MVIC (Medicon Valley Inhalation Consortium) and Upperton Pharma Solutions today announced a strategic collaboration designed to provide pharmaceutical and biotech companies with a seamless, end-to-end solution spanning early discovery, formulation development, preclinical support, and clinical trial manufacturing.
